Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation

被引:4
|
作者
Baek, Sung Uk [1 ]
Park, Min Seon [1 ]
Cho, Bum-Joo [1 ]
Park, In Won [1 ]
Kwon, Soonil [1 ]
机构
[1] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Ophthalmol, 22 Gwanpyeong Ro,170beon Gil, Anyang 14068, South Korea
基金
新加坡国家研究基金会;
关键词
MEAN PLATELET VOLUME; RANIBIZUMAB; METAANALYSIS; SEVERITY; THERAPY; MARKER;
D O I
10.1038/s41598-021-93384-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Uncontrolled diabetes has been associated with progression of diabetic retinopathy (DR) in several studies. Therefore, we aimed to investigate systemic and ophthalmic factors related to worsening of DR even after completion of panretinal photocoagulation (PRP). We retrospectively reviewed DR patients who had completed PRP in at least one eye with a 3-year follow-up. A total of 243 eyes of 243 subjects (mean age 52.6 +/- 11.6 years) were enrolled. Among them, 52 patients (21.4%) showed progression of DR after PRP (progression group), and the other 191 (78.6%) patients had stable DR (non-progression group). The progression group had higher proportion of proliferative DR (P=0.019); lower baseline visual acuity (P<0.001); and higher platelet count (P=0.048), hemoglobin (P=0.044), and hematocrit, (P=0.042) than the non-progression group. In the multivariate logistic regression analysis for progression of DR, baseline visual acuity (HR: 0.053, P<0.001) and platelet count (HR: 1.215, P=0.031) were identified as risk factors for progression. Consequently, we propose that patients with low visual acuity or high platelet count are more likely to have progressive DR despite PRP and require careful observation. Also, the evaluation of hemorheological factors including platelet counts before PRP can be considered useful in predicting the prognosis of DR.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy
    Azad, Amee D.
    Chen, Evan M.
    Hinkle, John
    Rayess, Nadim
    Wu, David
    Eliott, Dean
    Mruthyunjaya, Prithvi
    Parikh, Ravi
    OPHTHALMOLOGY RETINA, 2021, 5 (04): : 390 - 392
  • [22] Panretinal Photocoagulation vs Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy Reply
    Gross, Jeffrey G.
    Glassman, Adam R.
    JAMA OPHTHALMOLOGY, 2016, 134 (06) : 716 - 716
  • [23] Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Antie-Vascular Endothelial Growth Factor
    Obeid, Anthony
    Su, Daniel
    Patel, Samir N.
    Uhr, Joshua H.
    Borkar, Durga
    Gao, Xinxiao
    Fineman, Mitchell S.
    Regillo, Carl D.
    Maguire, Joseph I.
    Garg, Sunir J.
    Hsu, Jason
    OPHTHALMOLOGY, 2019, 126 (03) : 407 - 413
  • [24] Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
    Kartasasmita, Arief
    Harley, Ohisa
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1921 - 1926
  • [25] Associations and Prognostic Significance of Fluctuations in Diabetic Retinopathy Severity in Eyes Treated for Diabetic Macular Edema
    Cicinelli, Maria Vittoria
    Gregori, Giulia
    Rabiolo, Alessandro
    Tombolini, Beatrice
    Barresi, Costanza
    Pignatelli, Francesco
    Lattanzio, Rosangela
    Bandello, Francesco
    OPHTHALMOLOGICA, 2023, 246 (02) : 131 - 140
  • [26] Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
    Choi, Wungrak
    Kang, Hyun Goo
    Choi, Eun Young
    Kim, Sung Soo
    Koh, Hyoung Jun
    Kim, Min
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 10
  • [27] NATURAL COURSE OF VITREOMACULAR TRACTION IN EYES WITH DIABETIC RETINOPATHY AND FACTORS ASSOCIATED WITH SPONTANEOUS RELEASE
    Garip, Ruveyde
    Cinar, Ayca Kupeli
    Cinar, Abdulkadir Can
    Gurlu, Vuslat
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (08): : 1668 - 1674
  • [28] Characterization of Risk Profiles for Diabetic Retinopathy Progression
    Cunha-Vaz, Jose
    Mendes, Luis
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [29] Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy
    Azad, Amee D.
    Chen, Evan M.
    Hinkle, John
    Rayess, Nadim
    Wu, David
    Eliott, Dean
    Mruthyunjaya, Prithvi
    Parikh, Ravi
    OPHTHALMOLOGY RETINA, 2021, 5 (02): : 151 - 159
  • [30] Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy-A Review
    Gawecki, Maciej
    Kicinski, Krzysztof
    Bianco, Lorenzo
    Parodi, Maurizio Battaglia
    DIAGNOSTICS, 2024, 14 (01)